About BGI Genomics

BGI Genomics is the world’s leading provider of genomic sequencing services and proteomic services, now serving customers in more than 66 countries. We provide academic institutions, pharmaceutical companies, health care providers and other organizations with integrated genomic sequencing and proteomic services and solutions across a broad range of applications spanning:

• Basic research covering human, plant, animal and microbial species
• Clinical research in human health
• Genetic testing and screening
• Drug discovery and development
• Agriculture and Biodiversity preservation and sustainability

About MGI

MGI Tech Co., Ltd. (referred to as MGI) is committed to building core tools and technology to lead life science through intelligent innovation. MGI focuses on R&D, production and sales of DNA sequencing instruments, reagents, and related products to support life science research, agriculture, precision medicine and healthcare. MGI is a leading producer of clinical high-throughput gene sequencers, and its multi-omics platforms include genetic sequencing, mass spectrometry, medical imaging, and laboratory automation.

Founded in 2016, MGI has more than 1000 employees, nearly half of whom are R&D personnel. MGI operates in 39 countries and regions and has established multiple research and production bases around the world. Providing real-time, comprehensive, life-long solutions, its vision is to enable effective and affordable healthcare solutions for all.

About Jena Bioscience

Established in 1998 by a team of scientists from the Max-Planck-Institute of Molecular Physiology (Dortmund), Jena Bioscience utilizes more than 25 years of academic know-how to develop innovative reagents for clients from both research and industry in 100+ countries. To date, Jena Bioscience still remains an owner-operated business.

We manufacture in Germany according to international standards of DIN EN ISO 9001 (since 2008) & DIN EN ISO 14001 (since 2015) and EMAS EU verified environmental management (since 2015).

About Bio Basic

Research is expensive! Funding is critical for research projects, but it is becoming increasingly challenging to secure a sufficient amount as a stable source of income to move the project forward.

This may be as investors and governments not only find it difficult to gauge the reliability of long term investments in these projects, but they may also fail to understand the reasoning and complexities associated with the costs, as well as the time commitments required for these projects to be successful.

Because of this challenge, many projects either get cancelled or downscaled to accommodate the budget, thereby weakening the strength, effectivity and overall reliability of data from a given research project.

Our mission here at Bio Basic is to challenge this belief that research is expensive and aim to show that research can indeed be made affordable – especially quality research. Therefore our goal is to minimize the cost of research projects as to allow a lab of any size, even one with a shoe-string budget to be able to conduct large credible research projects.

About Nippon Genetics

NIPPON Genetics EUROPE provides cutting-edge products for the life science and biotechnology sector. With over 15 year of experiences, NIPPON Genetics EUROPE is specialized in sales, marketing and distribution of its own manufactured products as well as distribution of very innovative instrument and reagent companies.

Our product portfolio focusses on molecular biology, such as enzymes, kits and ready mixes for RT, PCR, qPCR, DNA Electrophoresis with safe DNA dyes and consumables, Protein electrophoresis with precast PAGE gels, protein marker and stains, as well as nucleic acid purification kits for DNA and RNA, and Gel documentation systems with CCD-cameras or CMOS-sensor using our unique safe blue/green LED light.